oxprenolol has been researched along with prazosin in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (42.11) | 18.7374 |
| 1990's | 3 (15.79) | 18.2507 |
| 2000's | 4 (21.05) | 29.6817 |
| 2010's | 4 (21.05) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Barritt, DW; Heaton, ST; Marshall, AJ; Pocock, J | 1 |
| Lizogub, VG; Piatak, OA; Yanovskii, GV | 1 |
| Kakuk, G; Kárpáti, I; Kurta, G; Mátyus, J | 1 |
| Damiĭonaĭtene, RA; Kuchinskene, ZZ; Rugenius, IuIu; Steponenene, RV; Vidugiris, AI | 1 |
| Freis, ED; Kyle, MC | 1 |
| Hodge, JV; Lubbe, WF | 1 |
| Mauersberger, H | 1 |
| Davey, DA; Dommisse, J; Roos, PJ | 1 |
| Hodge, JV; Kellaway, GS; Lubbe, WF | 1 |
| Farsang, C; Juhász, I; Kapocsi, J; Székács, B; Vajda, L | 1 |
| Lubbe, WF | 1 |
4 trial(s) available for oxprenolol and prazosin
| Article | Year |
|---|---|
Evaluation of beta blockade bendrofluazide, and prazosin in severe hypertension.
Topics: Adult; Aged; Atenolol; Bendroflumethiazide; Blood Pressure; Clinical Trials as Topic; Drug Evaluation; Drug Synergism; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Oxprenolol; Prazosin; Propranolol; Quinazolines | 1977 |
The influence of adrenoreactive preparations on clinical and haemodynamic parameters in patients with ischaemic heart disease.
Topics: Adult; Angina Pectoris; Coronary Artery Disease; Coronary Disease; Double-Blind Method; Exercise Test; Hemodynamics; Humans; Levodopa; Middle Aged; Nonachlazine; Oxprenolol; Prazosin; Propranolol; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta | 1991 |
[Changes in lipid fractions of blood during the treatment of hypertension with prazosin and trasicor].
Topics: Adult; Antihypertensive Agents; Female; Humans; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Lipids; Male; Middle Aged; Oxprenolol; Prazosin | 1990 |
Effect of prazosin and oxprenolol on plasma renin activity and blood pressure in patients with essential hypertension.
Topics: Adult; Blood Pressure; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Oxprenolol; Prazosin; Quinazolines; Renin | 1981 |
15 other study(ies) available for oxprenolol and prazosin
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Use of tensiomin (captopril) in the antihypertensive treatment of haemodialysis patients.
Topics: Adult; Antihypertensive Agents; Captopril; Drug Therapy, Combination; Female; Guanfacine; Guanidines; Humans; Hypertension; Male; Middle Aged; Nifedipine; Oxprenolol; Phenylacetates; Prazosin; Renal Dialysis | 1990 |
Serial measurements of systolic time intervals during treatment with hydrochlorothiazide alone and combined with other antihypertensive agents.
Topics: Antihypertensive Agents; Drug Therapy, Combination; Electrocardiography; Humans; Hydralazine; Hydrochlorothiazide; Hypertension; Male; Myocardial Contraction; Oxprenolol; Prazosin; Propranolol; Systole; Time Factors | 1985 |
Combined alpha- and beta-adrenoceptor antagonism with prazosin and oxprenolol in control of severe hypertension in pregnancy.
Topics: Acute Disease; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adult; Drug Therapy, Combination; Edema; Female; Humans; Hypertension; Infant, Newborn; Infant, Newborn, Diseases; Oxprenolol; Prazosin; Pregnancy; Pregnancy Complications, Cardiovascular; Proteinuria; Quinazolines | 1981 |
Effect of prazosin on blood pressure and plasma lipids in patients receiving a beta-blocker and diuretic regimen.
Topics: Aged; Blood Pressure; Chlorthalidone; Cholesterol; Drug Therapy, Combination; Female; Humans; Hypertension; Lipoproteins; Male; Oxprenolol; Prazosin; Quinazolines; Triglycerides | 1984 |
Prazosin and oxprenolol therapy in pregnancy hypertension.
Topics: Blood Pressure; Drug Therapy, Combination; Female; Humans; Hypertension; Oxprenolol; Prazosin; Pregnancy; Pregnancy Complications, Cardiovascular; Prospective Studies; Quinazolines | 1983 |
Antihypertensive treatment and fetal welfare in essential hypertension in pregnancy: a retrospective survey of experience with various regimes at National Women's Hospital, Auckland, 1970-80.
Topics: Antihypertensive Agents; Bed Rest; Benzothiadiazines; Birth Weight; Diuretics; Drug Therapy, Combination; Female; Fetal Growth Retardation; Humans; Hypertension; Infant Mortality; New Zealand; Oxprenolol; Prazosin; Pregnancy; Pregnancy Complications, Cardiovascular; Retrospective Studies; Smoking; Sodium Chloride Symporter Inhibitors | 1982 |
The management of hypertension in pregnancy.
Topics: Adult; Dihydralazine; Drug Therapy, Combination; Female; Humans; Hypertension; Oxprenolol; Prazosin; Pregnancy; Pregnancy Complications, Cardiovascular; Quinazolines | 1981 |